185 related articles for article (PubMed ID: 10706345)
1. Thirty-six-month outcome of prenatal cocaine exposure for term or near-term infants: impact of early case management.
Kilbride H; Castor C; Hoffman E; Fuger KL
J Dev Behav Pediatr; 2000 Feb; 21(1):19-26. PubMed ID: 10706345
[TBL] [Abstract][Full Text] [Related]
2. School-age outcome of children with prenatal cocaine exposure following early case management.
Kilbride HW; Castor CA; Fuger KL
J Dev Behav Pediatr; 2006 Jun; 27(3):181-7. PubMed ID: 16775513
[TBL] [Abstract][Full Text] [Related]
3. Drug-exposed infants and developmental outcome: effects of a home intervention and ongoing maternal drug use.
Schuler ME; Nair P; Kettinger L
Arch Pediatr Adolesc Med; 2003 Feb; 157(2):133-8. PubMed ID: 12580681
[TBL] [Abstract][Full Text] [Related]
4. Level of prenatal cocaine exposure and scores on the Bayley Scales of Infant Development: modifying effects of caregiver, early intervention, and birth weight.
Frank DA; Jacobs RR; Beeghly M; Augustyn M; Bellinger D; Cabral H; Heeren T
Pediatrics; 2002 Dec; 110(6):1143-52. PubMed ID: 12456912
[TBL] [Abstract][Full Text] [Related]
5. Developmental outcomes and environmental correlates of very low birthweight, cocaine-exposed infants.
Singer LT; Hawkins S; Huang J; Davillier M; Baley J
Early Hum Dev; 2001 Sep; 64(2):91-103. PubMed ID: 11440822
[TBL] [Abstract][Full Text] [Related]
6. Cognitive and motor outcomes of cocaine-exposed infants.
Singer LT; Arendt R; Minnes S; Farkas K; Salvator A; Kirchner HL; Kliegman R
JAMA; 2002 Apr; 287(15):1952-60. PubMed ID: 11960537
[TBL] [Abstract][Full Text] [Related]
7. Cocaine/polydrug use in pregnancy: two-year follow-up.
Chasnoff IJ; Griffith DR; Freier C; Murray J
Pediatrics; 1992 Feb; 89(2):284-9. PubMed ID: 1370867
[TBL] [Abstract][Full Text] [Related]
8. Neurological and developmental outcomes of prenatally cocaine-exposed offspring from 12 to 36 months.
Lewis MW; Misra S; Johnson HL; Rosen TS
Am J Drug Alcohol Abuse; 2004 May; 30(2):299-320. PubMed ID: 15230078
[TBL] [Abstract][Full Text] [Related]
9. Neurodevelopmental outcome of premature infants after antenatal phenobarbital exposure.
Shankaran S; Papile LA; Wright LL; Ehrenkranz RA; Mele L; Lemons JA; Korones SB; Stevenson DK; Donovan EF; Stoll BJ; Fanaroff AA; Oh W; Verter J
Am J Obstet Gynecol; 2002 Jul; 187(1):171-7. PubMed ID: 12114906
[TBL] [Abstract][Full Text] [Related]
10. Neurologic manifestations of in utero cocaine exposure in near-term and term infants.
King TA; Perlman JM; Laptook AR; Rollins N; Jackson G; Little B
Pediatrics; 1995 Aug; 96(2 Pt 1):259-64. PubMed ID: 7630680
[TBL] [Abstract][Full Text] [Related]
11. Prenatal cocaine and neuromotor outcome at four months: effect of duration of exposure.
Swanson MW; Streissguth AP; Sampson PD; Olson HC
J Dev Behav Pediatr; 1999 Oct; 20(5):325-34. PubMed ID: 10533991
[TBL] [Abstract][Full Text] [Related]
12. Birth outcome from a prospective, matched study of prenatal crack/cocaine use: I. Interactive and dose effects on health and growth.
Eyler FD; Behnke M; Conlon M; Woods NS; Wobie K
Pediatrics; 1998 Feb; 101(2):229-37. PubMed ID: 9445496
[TBL] [Abstract][Full Text] [Related]
13. The maternal lifestyle study: effects of substance exposure during pregnancy on neurodevelopmental outcome in 1-month-old infants.
Lester BM; Tronick EZ; LaGasse L; Seifer R; Bauer CR; Shankaran S; Bada HS; Wright LL; Smeriglio VL; Lu J; Finnegan LP; Maza PL
Pediatrics; 2002 Dec; 110(6):1182-92. PubMed ID: 12456917
[TBL] [Abstract][Full Text] [Related]
14. Increased incidence of intraventricular hemorrhage and developmental delay in cocaine-exposed, very low birth weight infants.
Singer LT; Yamashita TS; Hawkins S; Cairns D; Baley J; Kliegman R
J Pediatr; 1994 May; 124(5 Pt 1):765-71. PubMed ID: 7513757
[TBL] [Abstract][Full Text] [Related]
15. Adverse effects of fetal cocaine exposure on neonatal auditory information processing.
Potter SM; Zelazo PR; Stack DM; Papageorgiou AN
Pediatrics; 2000 Mar; 105(3):E40. PubMed ID: 10699142
[TBL] [Abstract][Full Text] [Related]
16. Newborn evaluations of toxicity and withdrawal related to prenatal cocaine exposure.
Eyler FD; Behnke M; Garvan CW; Woods NS; Wobie K; Conlon M
Neurotoxicol Teratol; 2001; 23(5):399-411. PubMed ID: 11711242
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of auditory brain-stem response in full-term infants of cocaine-abusing mothers.
Carzoli RP; Murphy SP; Hammer-Knisely J; Houy J
Am J Dis Child; 1991 Sep; 145(9):1013-6. PubMed ID: 1877558
[TBL] [Abstract][Full Text] [Related]
18. Cognitive functioning in 8- to 18-month-old drug-exposed infants.
Alessandri SM; Bendersky M; Lewis M
Dev Psychol; 1998 May; 34(3):565-73. PubMed ID: 9597365
[TBL] [Abstract][Full Text] [Related]
19. Psychological Functioning of Women Taking Illicit Drugs during Pregnancy and the Growth and Development of Their Offspring in Early Childhood.
Serino Ma D; Peterson Md BS; Rosen Md TS
J Dual Diagn; 2018; 14(3):158-170. PubMed ID: 29694295
[TBL] [Abstract][Full Text] [Related]
20. Cocaine-induced alterations in neuro-development.
Kosofsky BE
Semin Speech Lang; 1998; 19(2):109-21. PubMed ID: 9621399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
